These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 15626879)

  • 21. Phosphodiesterase inhibitors for the treatment of erectile dysfunction.
    Küthe A; Montorsi F; Andersson KE; Stief CG
    Curr Opin Investig Drugs; 2002 Oct; 3(10):1489-95. PubMed ID: 12431025
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Comparison of efficacy and safety of phosphodiesterase type 5 inhibitors in the treatment of erectile dysfunction].
    Chen Q; Wang N; Yao F; Lu X
    Zhonghua Nan Ke Xue; 2004 Apr; 10(4):302-4. PubMed ID: 15148932
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nitric oxide regulation of penile erection: biology and therapeutic implications.
    Burnett AL
    J Androl; 2002; 23(5):S20-6. PubMed ID: 12236169
    [No Abstract]   [Full Text] [Related]  

  • 24. Treating erectile dysfunction by endothelial rehabilitation with phosphodiesterase 5 inhibitors.
    Sommer F; Schulze W
    World J Urol; 2005 Dec; 23(6):385-92. PubMed ID: 16273418
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chapter 1: The management of erectile dysfunction: an AUA update.
    Montague DK; Jarow JP; Broderick GA; Dmochowski RR; Heaton JP; Lue TF; Milbank AJ; Nehra A; Sharlip ID;
    J Urol; 2005 Jul; 174(1):230-9. PubMed ID: 15947645
    [No Abstract]   [Full Text] [Related]  

  • 26. [The treatment options broaden. New chances for libido].
    Einecke U
    MMW Fortschr Med; 2002 May; 144(19):4-6. PubMed ID: 12116552
    [No Abstract]   [Full Text] [Related]  

  • 27. PDE-5 inhibitors: current status and future trends.
    Masson P; Lambert SM; Brown M; Shabsigh R
    Urol Clin North Am; 2005 Nov; 32(4):511-25, viii. PubMed ID: 16291042
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Diagnosis of erectile dysfunction--what is still needed today?].
    Weiske WH
    Urologe A; 2003 Oct; 42(10):1317-21. PubMed ID: 14569379
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vasoactive pharmacotherapy to cure erectile dysfunction: fact or fiction?
    Burnett AL
    Urology; 2005 Feb; 65(2):224-30. PubMed ID: 15708027
    [No Abstract]   [Full Text] [Related]  

  • 30. [Chronic treatment with PDE-5 inhibitors is there anything more than treating erectile dysfunction?].
    Vela Navarrete R; García Cardoso JV; López Farre A; Quesada Romero P; Pardo Montero M
    Actas Urol Esp; 2007 Mar; 31(3):179-84. PubMed ID: 17658146
    [No Abstract]   [Full Text] [Related]  

  • 31. Erectile dysfunction drugs and nonarteritic anterior ischemic optic neuropathy.
    Lee AG; Newman NJ
    Am J Ophthalmol; 2005 Oct; 140(4):707-8. PubMed ID: 16226524
    [No Abstract]   [Full Text] [Related]  

  • 32. Emergence and success of PDE5 inhibitors as effective therapy for erectile dysfunction.
    Manganiello V
    Int J Impot Res; 2004 Jun; 16 Suppl 1():S1-3. PubMed ID: 15224126
    [No Abstract]   [Full Text] [Related]  

  • 33. Commentaries on Jackson et al. "Successful withdrawal of oral long-acting nitrates to facilitate phosphodiesterase type 5 inhibitor use in stable coronary disease patients with erectile dysfunction".
    Kloner RA; Montorsi P; DeBusk RF
    J Sex Med; 2005 Sep; 2(5):740-2; author reply 742. PubMed ID: 16422835
    [No Abstract]   [Full Text] [Related]  

  • 34. Clinical evaluation of erectile dysfunction in the era of PDE-5 inhibitors.
    Lobo JR; Nehra A
    Urol Clin North Am; 2005 Nov; 32(4):447-55, vi. PubMed ID: 16291036
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Optimisation of PDE5 inhibitor therapy in men with erectile dysfunction: converting "non-responders" into "responders".
    Eardley I
    Eur Urol; 2006 Jul; 50(1):31-3. PubMed ID: 16517052
    [No Abstract]   [Full Text] [Related]  

  • 36. Salvage techniques for phosphodiesterase 5 inhibitor therapy: purposeful but how much?
    Burnett AL
    Eur Urol; 2006 Jul; 50(1):29-30. PubMed ID: 16567036
    [No Abstract]   [Full Text] [Related]  

  • 37. [After taking the table, immediate sex? New potency pill allows more time for love life].
    MMW Fortschr Med; 2004 May; 146(19):64. PubMed ID: 15357491
    [No Abstract]   [Full Text] [Related]  

  • 38. Clinical update on phosphodiesterase type-5 inhibitors for erectile dysfunction.
    Briganti A; Salonia A; Deho' F; Zanni G; Barbieri L; Rigatti P; Montorsi F
    World J Urol; 2005 Dec; 23(6):374-84. PubMed ID: 16273417
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phosphodiesterase type 5 inhibitors: a biochemical and clinical correlation survey.
    Kim NN
    Int J Impot Res; 2003 Oct; 15 Suppl 5():S13-9. PubMed ID: 14551572
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [PDE-5 inhibitor with improved pharmacokinetics. Far-reaching return to normality].
    MMW Fortschr Med; 2003 Mar; 145(11):56-7. PubMed ID: 12688198
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.